Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
pasireotide somatostatin receptor type 1 small molecule Successful target TTD , drugbank , DGIDB Pituitary Gland[MeSHID:D010902]
Pituitary-dependent Cushing's disease[MeSHID:D047748]
Pituitary Diseases[MeSHID:D010900]
Operative Surgical Procedures[MeSHID:D013514]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 6.63 approved unknown
pasireotide somatostatin receptor type 1 small molecule Successful target TTD , drugbank , DGIDB Pituitary Gland[MeSHID:D010902]
Pituitary-dependent Cushing's disease[MeSHID:D047748]
Pituitary Diseases[MeSHID:D010900]
Operative Surgical Procedures[MeSHID:D013514]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 6.63 approved agonist
pasireotide somatostatin receptor type 2 small molecule Successful target TTD , drugbank , DGIDB Pituitary Gland[MeSHID:D010902]
Pituitary-dependent Cushing's disease[MeSHID:D047748]
Pituitary Diseases[MeSHID:D010900]
Operative Surgical Procedures[MeSHID:D013514]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 4.68 approved unknown
pasireotide somatostatin receptor type 2 small molecule Successful target TTD , drugbank , DGIDB Pituitary Gland[MeSHID:D010902]
Pituitary-dependent Cushing's disease[MeSHID:D047748]
Pituitary Diseases[MeSHID:D010900]
Operative Surgical Procedures[MeSHID:D013514]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 4.68 approved agonist
pasireotide somatostatin receptor type 3 small molecule Successful target TTD , drugbank , DGIDB Pituitary Gland[MeSHID:D010902]
Pituitary-dependent Cushing's disease[MeSHID:D047748]
Pituitary Diseases[MeSHID:D010900]
Operative Surgical Procedures[MeSHID:D013514]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 6.63 approved unknown
pasireotide somatostatin receptor type 3 small molecule Successful target TTD , drugbank , DGIDB Pituitary Gland[MeSHID:D010902]
Pituitary-dependent Cushing's disease[MeSHID:D047748]
Pituitary Diseases[MeSHID:D010900]
Operative Surgical Procedures[MeSHID:D013514]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 6.63 approved agonist
pasireotide somatostatin receptor type 5 small molecule Successful target TTD , drugbank , DGIDB Pituitary Gland[MeSHID:D010902]
Pituitary-dependent Cushing's disease[MeSHID:D047748]
Pituitary Diseases[MeSHID:D010900]
Operative Surgical Procedures[MeSHID:D013514]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 5.68 approved agonist
pasireotide somatostatin receptor type 5 small molecule Successful target TTD , drugbank , DGIDB Pituitary Gland[MeSHID:D010902]
Pituitary-dependent Cushing's disease[MeSHID:D047748]
Pituitary Diseases[MeSHID:D010900]
Operative Surgical Procedures[MeSHID:D013514]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 5.68 approved unknown
click here to return to the previous page